Boston-based medical device company AVS (Amplitude Vascular Systems) raised $20 million in Series B funding on Thursday to bring its arterial disease treatment closer to FDA clearance. The financing ...
BOSTON--(BUSINESS WIRE)--AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced today that it ...
BOSTON--(BUSINESS WIRE)--AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced today that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results